A series of febrifugine analogues were designed and synthesized. Antimalarial activity evaluation of the synthetic compounds indicated that these derivatives had a strong inhibition against both chloroquine-sensitive and -resistant Plasmodium falciparum parasites. Many of them were found to be more active than febrifugine hydrochloride. The tested analogues had also a significant cytotoxicity against four cancer cell lines (KB, MCF7, LU1 and HepG2). Among the synthetic analogues, two compounds 17b and 17h displayed a moderate cytotoxicity while they exhibited a remarkable antimalarial activity.
(a) KoepfliJ.B., MeadJ.F., BrockmanJ.A.J. (1947) An alkaloid with high antimalarial activity from Dichroa febrifuga. Journal of the American Chemical Society, 69, 1837–1837;(b) Coatney GR, Cooper, WC, Culwell WB, White WC, Imboden CAJ. (1950) Studies in human malaria. XXV. Trial of febrifugine, an alkaloid obtained from Dichroa febrifuga Lour., against the Chesson strain of Plasmodium vivax. The Journal of the National Malaria Society, 9, 183–186.
2.
(a) De SmetPagm. (1947) The role of plant-derived drugs and herbal medicines in healthcare. Drugs, 54, 801–840;(b) Jiang S, Zeng Q, Gettayacamin M, Tungtaeng A, Wannaying S, Lim A, Hansukjariya P, Okunji CO, Zhu S, Fang D. (2005) Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrobial Agents and Chemotherapy, 49, 1169–1176.
3.
(a) PinesM., SnyderD., YarkoniS., NaglerA. (2003) Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biology of Blood and Marrow Transplantation, 9, 417–425;(b) Pines M, Nagler A. (1998) Halofuginone: a novel antifibrotic therapy. General Pharmacology: The Vascular System, 30, 445–450; (c) De Jonge MJ, Dumez H, Verweij J, Yarkoni S, Snyder D, Lacombe D, Marréaud S, Yamaguchi T, Punt CJ, van Oosterom A. (2006) Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours. European Journal of Cancer, 42, 1768–1774; (d) Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. (2011) Phase II AIDS malignancy consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. Journal of Acquired Immune Deficiency Syndromes, 56, 64–68.
4.
(a) Rad-MoghadamK., MohseniM. (2003) An expeditious and solvent-free route to the synthesis of 2-substituted quinazolin-4(3H)-ones under microwave conditions. Journal of Chemical Research, 487–488; (b) Li F, Feng Y, MengQ, Li W, Li Z, Wang Q, Tao F. (2007) An efficient construction of quinazolin-4(3H)-ones under microwave irradiation. ARKIVOC, i, 40–50.
5.
LiuR.C., HuangW., MaJ.Y., WeiB.G., LinG.Q. (2009) BF3·Et2O catalyzed diastereoselective nucleophilic reactions of 3-silyloxypiperidine N, O-acetal with silylenol ether and application to the asymmetric synthesis of (+)-febrifugine. Tetrahedron Letters, 50, 4046–4049.
6.
KikuchiH., YamamotoK., HoroiwaS., HiraiS., KasaharaR., HariguchiN., MatsumotoM., OshimaY. (2006) Exploration of a new type of antimalarial compounds based on febrifugine. Journal of Medicinal Chemistry, 49, 4698–4706.
7.
ZhuS., WangJ., ChandrashekarG., SmithE., LiuX., ZhangY. (2010) Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents. European Journal of Medicinal Chemistry, 45, 3864–3869.
8.
YadavJ.S., ReddyB.V.S., BasakA.K., NarsaiahA.V. (2004) Recyclable 2nd generation ionic liquids as green solvents for the oxidation of alcohols with hypervalent iodine reagents. Tetrahedron, 60, 2131–2135.
9.
BarringerD.F.J., BerkelhemmerG., CarterS.D., GoldmanL., LanzilottiA.E. (1973) Stereochemistry of fegrifugine. I. Equilibrium between cis- and trans-(3-substituted 2-piperidyl)-2-propanones. Journal of Organic Chemistry, 38, 1933–1937.
10.
WijdevenM.A., van den BergR.J.F., WijtmansR., BotmanP.N.M., BlaauwR.H., SchoemakerH.E., van DelftF.L., RutjesFpjt. (2009) Complementary chemoenzymatic routes to both enantiomers of febrifugine. Organic & Biomolecular Chemistry, 7, 2976–2980.
11.
MosmannT. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63.
12.
DesjardinsR.E., CanfieldC.J., HaynesJ.D., ChulayJ.D. (1979) Quantitative assessment of antimalarial activity in vitro by a semi automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710–718.
